spinandcoinmaster| U.S. stocks change| Hims surged 23% to launch weight-loss drugs 85% lower than Novo Nordisk

Affordable health care company Hims & Hers Health Incspinandcoinmaster. The first weight-loss drugspinandcoinmaster, each needle is 85% lower than Novo Nordisk Wegovy and about 15% lower than Lilly. Hims's U.S. stocks widened to 23% at the beginning of the session, Lilly rose more than 1.1%, Roche ADR rose about 0.6%, and Novo Nordisk ADR rose 0.3%.

Tags:

Prev: oscarsgrind| China Huaxing (00485.HK) receives liquidation petition
Next: onlinepokerformoney| Mandi Technology Shares (01400.HK) plans to place up to 300 million shares with a net raise of HK$29.4 million